Order Toll Free: 1-888-848-1945. You save an additional 20% by ordering online.

Welcome! Log in:

Forgot password?
Do I need an account to order?
River Professional Group - Your Neighborhood Drugstore Online

Frequently Asked Questions

Do you carry Namenda/Ebixa (memantine HCI)?

Short Answer

Yes, look for Memantine.

Long Answer

Namenda (memantine hydrochloride), also known as Ebixa, is for patients with moderate to severe dementia from Alzheimer’s disease. It is one of a group of drugs called NMDA (n-methyl-D-aspartate) receptor antagonists.

It is not a cure for Alzheimer's disease, but may delay cognitive decline or assist with behavioral symptoms. Currently available medications can be divided into two main groups:

  • Acetylcholine Esterase Inhibitors
  • NMDA Receptor Antagonists

Namenda can be used on its own or in combination with cholinesterase inhibitors (i.e., Aricept, Exelon, or Reminyl). In controlled clinical trials, Namenda has been used in combination with Aricept.

If you do not find the medication you are looking for in our database, contact us to let us know what you need. We will source it from one of our suppliers and let you know the availability and price of your medication.

Additional Information

Drug treatments for Alzheimer's disease (Alzheimers.org)
Memantine blocks a messenger chemical known as glutamate. Glutamate is released in excessive amounts when brain cells are damaged by Alzheimer's disease and this causes the brain cells to be damaged further. Memantine can protect brain cells by blocking these effects of excess glutamate.
Memantine for Alzheimer's Disease (WebMD.com)
Memantine is the first in one class of medicines developed to treat Alzheimer's disease. It has been available in Europe for years but was only recently approved for treating Alzheimer's disease in the United States. It works in a completely different way compared to other Alzheimer's disease medicines.
Drug Memantine Ineffective for Mild Alzheimer's, Study Finds (HealthDay.com)
While some studies suggest the drug is effective in treating moderate to severe Alzheimer's disease, "in mild Alzheimer's disease there is a lack of evidence that it works," said lead researcher Dr. Lon S. Schneider, a professor of psychiatry, neurology and gerontology at the University of Southern California Keck School of Medicine.